/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
Based in San Diego, California, ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. Valued at a market cap of $33.6 billion, the company primarily provides generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. It is scheduled to announce its fiscal Q2 earnings results on Wednesday, Jan. 22.
Before this event, analysts projected the medical instruments provider to report a profit of $2.29 per share, up 21.8% from $1.88 per share in the year-ago quarter. Moreover, the company has a promising trajectory of consistently beating Wall Street's bottom-line estimates in the last four quarters. In Q1 2025, RMD’s adjusted EPS of $2.20 outpaced the consensus estimates by 8.4%.